Effectiveness of Medium-Dose Cytarabine Combined With Venetoclax for Consolidation Therapy in Elderly Patients With Intermediate to High-Risk Acute Myeloid Leukemia

NCT06990321 · clinicaltrials.gov ↗

PHASE3

Phase

RECRUITING

Status

68

Enrollment

OTHER

Sponsor class

Conditions

Acute Myeloid Leukemia (AML)
Elderly

Interventions

DRUG: Intermediate-dose Cytarabine in Combination with Venetoclax

Sponsor

Yehui Tan